Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Intestinal involvement in graft versus host disease in children : an overview by the ESPGHAN Gastroenterology Committee
Avtorji:ID Vincent, Marina (Avtor)
ID Assa, Amit (Avtor)
ID Borrelli, Osvaldo (Avtor)
ID Homan, Matjaž (Avtor)
ID Martin-de-Carpi, Javier (Avtor)
ID Mišak, Zrinjka (Avtor)
ID Puoti, Maria Giovanna (Avtor)
ID Scheers, Isabelle (Avtor)
ID Sila, Sara (Avtor)
ID Strisciuglio, Caterina (Avtor)
ID Tzivinikos, Christos (Avtor)
ID Dolinšek, Jernej (Avtor)
ID Mas, Emmanuel (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (770,51 KB)
MD5: 082C107B5596F525C6A2E110572FEB16
 
URL URL - Izvorni URL, za dostop obiščite https://onlinelibrary.wiley.com/doi/10.1002/jpn3.70087
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Graft versus host disease (GVHD) is a complication that frequently occurs afterhaematopoietic stem cell transplantation and concerns many children in paediatrichaematology‐oncology and bone marrow transplantation departments. It can affectvarious organs, with the skin, gastrointestinal tract and liver being the most com-monly involved. To confirm intestinal GVHD and to rule out differential diagnosesendoscopy is frequently needed. Currently, there are no specific consensus rec-ommendations concerning the best method for endoscopic exploration and medicalmanagement of this disease in children, with limited studies available, including alow number of patients. Sigmoidoscopy could be initially proposed under sedation. Ifsigmoidoscopy is normal or if a general anaesthesia is required, colonoscopy andupper endoscopy should be planned, avoiding duodenal biopsy because of the riskof duodenal haematoma. Regarding therapeutic options, corticosteroids are thefirst‐line treatment for GVHD. Ruxolitinib, a Janus kinase inhibitor, is indicated forchildren aged 12 years and older with acute or chronic GVHD who have aninadequate response to corticosteroids or other systemic therapies. Nutritionalsupport has a key role in the management of intestinal GVHD and should beconsidered to guarantee the best possible evolution of intestinal GVHD.
Ključne besede:GVHD, children, complication, endoscopy, haematopoietic stem cell transplantation, intestine
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 246–255
Številčenje:Vol. 81, iss 2
PID:20.500.12556/DiRROS-24121 Novo okno
UDK:616-053.2
ISSN pri članku:1536-4801
DOI:doi.org/10.1002/jpn3.70087 Novo okno
COBISS.SI-ID:237958403 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 2. 6. 2025;
Datum objave v DiRROS:14.11.2025
Število ogledov:125
Število prenosov:56
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Journal of pediatric gastroenterology and nutrition
Skrajšan naslov:J. pediatr. gastroenterol. nutr.
Založnik:Lippincott Williams & Wilkins
ISSN:1536-4801
COBISS.SI-ID:3611412 Novo okno

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Nazaj